Example: Heart Attack
Clinical Trials Sponsored by Capital Innovation
Total 1 results
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Show vendors
Sponsors and Collaborators
- National Cancer Institute (NCI)
- Assiut University
- First Hospital of Shijiazhuang City
- Hospital, Vannes
- Charlotte Gastroenterology and Hepatology
- GlaxoSmithKline
- Universitätsklinikum Tulln
- Groupe Pasteur Mutualité
- AstraZeneca
- M.D. Anderson Cancer Center
- Novartis Pharmaceuticals
- Mayo Clinic
- Cairo University
- John Kempen
- Amphia Hospital
- Mid-Atlantic Nutrition Obesity Research Center
- BKK Mobil Oil
- Pfizer
- Beijing DMS Pharma Ltd.
- Assistance Publique - Hôpitaux de Paris
- View Full List
Medical Conditions
- Leucocytosis
- Hematopoietic and Lymphoid Cell Neoplasm
- Pre-terminal Cancer
- Infection Gastrointestinal
- Nutritional Status in Hospitalised Geriatric Patients
- Blood Flow Indexes
- ASA 1-2 Requiring Intravenous Cannulation for General Anaesthesia
- Breast Cancer
- Depression
- Hypertension
- Asthma
- Gastroesophageal Reflux Disease With Dyspepsia Symptoms
- Obesity
- HIV Infections
- Prostate Cancer
- Corpus Callosum Malformation
- Blood Coagulation Disorder Due to Liver Disease
- Coronary Artery Disease
- Pain
- Stroke
- View Full List
Drug Interventions
- Triamcinolone Acetonide 4 mg intravitreal injection
- AC-150A 0.1%
- docetaxel
- Cisplatin
- enalapril and other angiotensin converting enzyme inhibitors; losartan and other angiotensin receptor blockers
- Carboplatin
- CA-008
- Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato]
- Dexamethasone
- Prednisone
- Cyclophosphamide
- M4344 10 mg BIW
- Dicofenac
- Paclitaxel
- Capecitabine
- Gemcitabine
- Bevacizumab
- 100 mg INX-08189 QD
- Iodixanol, Ioversol, Iopromide
- Efficacy of Enbrel subcutaneously at Week 36
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in China
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Croatia
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Hungary
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Malawi
- Contract Research Organizations in Norway
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in South Africa
- Contract Research Organizations in Suriname
- CRO list by country